Latest Period
Q4 2025
Security Snapshot
Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) Institutional Ownership
CUSIP: 738920107
13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025
Institutions Reporting
30
Shares (Excl. Options)
6,823,464
Price
$0.13
- Type / Class
- Equity / Common Stock
- Symbol
- ASBP on Nasdaq
- Shares outstanding
- 138,530,928
- Price per share
- $0.08
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 6,823,464
- Total reported value
- $899,822
- % of total 13F portfolios
- 0%
- Share change
- +3,700,421
- Value change
- +$486,842
- Number of holders
- 30
- Price from insider filings
- $0.08
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ASBP - Aspire Biopharma Holdings, Inc. - Common Stock is tracked under CUSIP 738920107.
- 30 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 25 to 30 between Q3 2025 and Q4 2025.
- Reported value moved from $645,607 to $899,822.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 738920107?
CUSIP 738920107 identifies ASBP - Aspire Biopharma Holdings, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 738920107:
Significant Owners of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 7.8% | $860,000 | 10,750,000 | Ardsley Advisory Partners LP | 31 Dec 2025 | |||
| Friedman Lance | 4.5% | -42% | $1,037,706 | -$782,315 | 2,207,886 | -43% | Lance Friedman | 06 May 2025 |
| Harraden Circle Investments, LLC | 0.31% | $70,500 | 150,000 | Harraden Circle Investments, LLC | 31 Mar 2025 |
As of 31 Dec 2025, 30 institutional investors reported holding 6,823,464 shares of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP). This represents 4.9% of the company’s total 138,530,928 outstanding shares.